Stock USNA USANA HEALTH SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials USANA Health Sciences, Inc.

Equities

USNA

US90328M1071

Food Processing

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
43.47 USD +0.76% Intraday chart for USANA Health Sciences, Inc. -1.50% -18.90%
Mar. 11 Usana Health Sciences Insider Sold Shares Worth $539,539, According to a Recent SEC Filing MT
Mar. 11 Usana Health Sciences Insider Sold Shares Worth $257,022, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 1,700 1,620 1,970 1,022 1,025 836.4 -
Enterprise Value (EV) 1 1,700 1,308 1,730 733.4 695.7 448.4 387.3
P/E ratio 17.8 x 13.1 x 17.7 x 14.8 x 16.2 x 16 x 13.9 x
Yield - - - - - - -
Capitalization / Revenue 1.6 x 1.43 x 1.66 x 1.02 x 1.11 x 0.94 x 0.91 x
EV / Revenue 1.6 x 1.15 x 1.46 x 0.73 x 0.76 x 0.5 x 0.42 x
EV / EBITDA 10.6 x 6.88 x 9.44 x 6.06 x 6.58 x 3.94 x 3.24 x
EV / FCF - 8.93 x 16 x 8.01 x 13.8 x 7.33 x 5.52 x
FCF Yield - 11.2% 6.27% 12.5% 7.27% 13.6% 18.1%
Price to Book - - - - 2.09 x 1.51 x 1.35 x
Nbr of stocks (in thousands) 21,643 21,038 19,462 19,206 19,130 19,241 -
Reference price 2 78.55 77.02 101.2 53.20 53.60 43.47 43.47
Announcement Date 2/4/20 2/9/21 2/8/22 2/7/23 2/6/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 1,061 1,135 1,186 998.6 921 889.8 920.9
EBITDA 1 160.9 190.2 183.2 121 105.8 113.7 119.4
EBIT 1 146.2 176.5 170.2 107.6 93.07 78.98 91.37
Operating Margin 13.78% 15.55% 14.34% 10.78% 10.11% 8.88% 9.92%
Earnings before Tax (EBT) 1 150.5 177.9 170.6 108.6 102.5 86.1 98.87
Net income 1 100.5 124.7 116.5 69.35 63.79 52.5 60.31
Net margin 9.48% 10.99% 9.82% 6.94% 6.93% 5.9% 6.55%
EPS 2 4.410 5.860 5.730 3.590 3.300 2.725 3.125
Free Cash Flow 1 - 146.5 108.5 91.53 50.55 61.18 70.19
FCF margin - 12.91% 9.14% 9.17% 5.49% 6.88% 7.62%
FCF Conversion (EBITDA) - 76.99% 59.2% 75.64% 47.79% 53.81% 58.79%
FCF Conversion (Net income) - 117.49% 93.1% 131.99% 79.25% 116.53% 116.39%
Dividend per Share - - - - - - -
Announcement Date 2/4/20 2/9/21 2/8/22 2/7/23 2/6/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 274.4 267.3 272.9 264.5 233.3 228 248.4 238.2 213.4 221.1 226.8 224 215.6 223.3 234.6
EBITDA 1 44.01 34.79 36.35 32.72 26.1 25.84 30.14 27.62 - 27.13 30.7 29.4 23.6 30 32.1
EBIT 1 40.77 31.5 33.07 29.37 22.63 22.55 26.84 24.4 17.61 24.22 19.84 19.97 17.13 22.05 23.17
Operating Margin 14.86% 11.79% 12.12% 11.1% 9.7% 9.89% 10.81% 10.24% 8.25% 10.95% 8.74% 8.91% 7.94% 9.87% 9.88%
Earnings before Tax (EBT) 1 40.35 31.65 33.29 29.31 23.22 22.8 28.5 26.81 20.53 26.61 21.79 21.69 18.86 23.76 25.19
Net income 1 27.33 20.32 22.47 19.16 14.93 12.8 18.38 17.29 11.35 16.77 13.3 13.23 11.47 14.51 15.35
Net margin 9.96% 7.6% 8.23% 7.24% 6.4% 5.61% 7.4% 7.26% 5.32% 7.58% 5.86% 5.9% 5.32% 6.5% 6.55%
EPS 2 1.360 1.030 1.150 1.000 0.7800 0.6600 0.9500 0.8900 0.5900 0.8700 0.6900 0.6900 0.5950 0.7500 0.8000
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 10/26/21 2/8/22 4/26/22 7/26/22 10/25/22 2/7/23 4/25/23 7/25/23 10/24/23 2/6/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - - -
Net Cash position 1 - 312 240 288 330 388 449
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - 146 108 91.5 50.6 61.2 70.2
ROE (net income / shareholders' equity) - - 27.8% 16.7% 13.7% 10% 10.3%
ROA (Net income/ Total Assets) - - 19.1% - 10.4% 8.1% 9.1%
Assets 1 - - 609.3 - 614.7 648.2 662.7
Book Value Per Share 2 - - - - 25.70 28.80 32.20
Cash Flow per Share 2 - - - - 3.690 4.080 4.820
Capex 1 16.6 15.1 12.8 10.4 14.5 13.7 13.9
Capex / Sales 1.56% 1.33% 1.08% 1.04% 1.57% 1.54% 1.5%
Announcement Date 2/4/20 2/9/21 2/8/22 2/7/23 2/6/24 - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for USANA Health Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
43.47 USD
Average target price
56.5 USD
Spread / Average Target
+29.97%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-18.90% 836M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+8.20% 7.78B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+0.34% 7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+10.20% 6.52B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-8.10% 3.67B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-13.13% 3.44B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-14.57% 1.17B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+8.34% 934M
HERBALIFE LTD. Stock Herbalife Ltd.
-42.27% 879M
GRAPE KING BIO LTD Stock Grape King Bio Ltd
+0.32% 711M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. USNA Stock
  4. Financials USANA Health Sciences, Inc.